DNLI
Denali Therapeutics Inc.
$18.00
+$0.84(+4.90%)
61
Overall
60
Value
63
Tech
--
Quality
Market Cap
$2.44B
Volume
1.45M
52W Range
$10.57 - $26.18
Target Price
$31.60
EPS Estimates Overview
| Current Quarter | $-0.76 | Next Quarter | $-0.79 |
| Current Year | $-3.01 | Next Year | $-3.04 |
| QoQ Growth | -3.9% | YoY Growth | -1.0% |
| 3Y EPS CAGR | -2.5% | Target Price | $31.60 |
| Consensus | Buy | Upside | +75.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNLI | $18.00 | +4.9% | 1.45M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Denali Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW